ALT
Altimmune, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.04
−4.67%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-19.4%
Return on equity
-17.4%
Return on assets
-19.7%
Return on invested capital
0.00x
Asset turnover
-$76.5M
Cash from operations
$1.68
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026